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Abstract
Our implementation science study focuses on implementing a new way of practice and offers methodological speciﬁcity about
how to rapidly investigate an individually tailored precision medicine intervention. A qualitative study advancing a new
methodology for speedily identifying barriers and enablers to implementation in the context of childhood cancer. Data were
collected through rapid ethnography, coded using the Consolidated Framework for Implementation Research, and analysed by
Sentiment Analysis. Thirty-eight data collection events occurred during 14 multidisciplinary tumour board meetings, 14
curation meetings, and 10 informal conversations. Sentiment Analysis distilled Consolidated Framework for Implementation
Research codes to reveal key barriers and enablers to implementation. A trafﬁc light labelling system has been used to present
levels of positivity and negativity (green for strong enablers and red for strong barriers), highlighting levels of concern regarding
implementation. Within the intervention design characteristics, “Adaptability” was the strongest enabler and “Design quality
and safety” the strongest barrier. Among the contextual factors: “Networks and communication” were the strongest enabler,
and “Available resources” were the strongest barrier. Overall, there was a higher percentage of negative sentiment towards
intervention design characteristics and contextual factors than positive sentiment, while more concerns were raised about
intervention design factors than contextual factors. This study offers a rapid qualitative data collection and analytic methodological roadmap for establishing barriers and enablers to a paediatric precision medicine intervention.
Keywords
Implementation, cancer, methodology, precision medicine, rapid ethnography
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Introduction
The ZERO Childhood Cancer Personalised
Medicine Model
The ZERO Program is an innovative Program that involves a
transdisciplinary approach to decision-making in developing
individually tailored cancer treatments for children through its
embedded early phase clinical trial: PRecISion Medicine for
Childhood Cancer (PRISM). The ZERO Program and PRISM
trial aim to carry out tumour molecular proﬁling and drug
screening by completing and returning this evidence together
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with an interpretation of data to the treating physician in a
clinically relevant timeframe. Curation meetings (CMs) and a
national multidisciplinary tumour board (MTB) are newly
formed strategies designed for the national clinical trial
(Rankin et al., 2018; Rolfo et al., 2018). Attendees include
representation across a range of speciﬁc clinical and scientiﬁc
areas working together to adopt a new way of delivering
childhood cancer care. For example, the diagnostic platform
includes comprehensive testing of both tumour and patient
genome. The information derived from the tests are assessed
in CMs that include genomic, drug curation, and biological
scientists, bioinformaticians, molecular oncology clinicians,
and clinical geneticists who critically appraise the validity of
the sample, variants of known and unknown signiﬁcance, and
determine clinical signiﬁcance and relevance before being
shared through a national MTB. The MTB consists of paediatric oncologists, molecular oncology specialists, genomic
and drug curation scientists, and treating clinicians. They aim
to assess and reach a consensus on the information tabled from
the curation teams. Clinically relevant information is fed back
to the treating physician, that is, if there is an actionable
recommendation (novel drug target/referral to cancer
predisposition/change in diagnosis).

An Individually Tailored Intervention
The complete process of delivering precision medicine in
childhood cancer care, from testing and analysis, to discussion
and information sharing followed by a precision medicine
recommendation, is the ZERO Program’s intervention (Baker
et al., 2010). This signiﬁcant departure from ‘standard’ oncological approaches (National Academies of Sciences &
Medicine, 2016) bases treatment recommendations on potential drug targets and genomic data – thus introducing a new
framework of evidence-based practice. The content of each
child’s case includes discussions at CMs. Following CMs, the
clinically relevant information is shared through the national
MTB. This has implications for changes to real-time delivery
of care and effects (Rowbotham et al., 2019). Precision
medicine is placing new demands on childhood cancer care.
For example, healthcare professionals are having to adopt new
ways of practice that include changing their behaviour, such as
role changes, professional changes in decision-making and
new ways of communication as well as acquiring and assimilating new workﬂows and requiring ever-increasing
knowledge of genomic medicine (Horowitz et al., 2019;
McGill et al., 2020; Willemsen et al., 2019; Wong et al., 2020).
Likewise, our complex intervention requires a change in the
behaviour of healthcare professionals to meet the demands of
changing practice making healthcare professionals the focus
of this intervention (Keith et al., 2017; Morrow et al., 2019;
Rixon et al., 2016; Taylor et al., 2014). Change can be
challenging without a clear understanding of which determinants act as enablers to positive implementation and which
are barriers (Smith et al., 2021a). Understanding enablers of

International Journal of Qualitative Methods

and barriers to change is vital to tailoring implementation
strategies and creating greater surety over long-term effectiveness (Atkins et al., 2017).

The Consolidated Framework for Implementation
Research
The Consolidated Framework for Implementation Research
(CFIR) (Damschroder et al., 2009) is a determinant framework
that can help identify and explain factors that inﬂuence implementation and recognise how multiple levels of behaviour
change, operate and inﬂuence implementation (Squires et al.,
2015). CFIR includes factors related to the “intervention
design” itself, the “outer context” (e.g., the level at which the
implementing organisation is networked with other
organisations/external inﬂuences on the intervention), the
“inner setting” (e.g., the internal networks and communications that can inﬂuence implementation), “individuals involved” (e.g., their knowledge and beliefs), and the “process”
under consideration (e.g., planning and reﬂection work).
However, some authors argue that the framework may require
tailoring of factor deﬁnitions, in order to ﬁt the needs of any
given study context (Damschroder et al., 2022; Keith et al.,
2017; Means et al., 2020; Safaeinili et al., 2020).
McDonald (2013) framed CFIR in terms of its intervention
design characteristics but also conceptualised grouping the
contextual domains together, a practice subsequently followed
by others (Holen-Rabbersvik et al., 2020; Wiig et al., 2019). In
line with this conceptualisation, we grouped the contextual
domains (inner, outer, individual characteristics and processes) for greater ﬂexibility in line with the new practice
demands of the transdisciplinary groups interacting in this
precision medicine study with CFIR’s intervention design
characteristics depicting the intervention design. This included factors such as, “Evidence, strength and quality” (do
people believe in the strength of the evidence available) and
“Complexity” (views on whether the intervention is too
complex to implement). We extended McDonald’s (2013)
conceptualisation of CFIR to indicate combined and individual inﬂuencers of implementation to ensure a comprehensive approach towards our assessment of intervention
implementation within this complex context.

A Methodological Roadmap to Speeding Up
Qualitative Data Collection and Analysis
The speed of delivering information is no less important than
its accuracy (McNall et al., 2004). The CFIR approach has
been criticised when applied recently to a precision medicine
context for being time-intensive and potentially delaying the
identiﬁcation of ﬁndings (Best et al., 2021). In line with this
criticism, the CFIR approach indicates some recent attempts
by CFIR’s creators and other authors to speed up the qualitative data collection and deductive analytic process for
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contexts with rapid change (Gale et al., 2019; Nevedal et al.,
2021; Zucco et al., 2021).
However, despite the potential to speed up the qualitative
data collection and analytic process, and ﬁt for within highstake contexts (e.g., precision medicine contexts, COVID-19,
etc.), this idea has not been taken up in recent qualitative
research studies using CFIR approaches applied to precision
medicine models of care (Best et al., 2021; Levy et al., 2019;
McGill et al., 2020; Zebrowski et al., 2019). For example,
these studies applied static interviews and lengthy transcription and analysis procedures to make sense of data (Best et al.,
2021; McGill et al., 2020; Zebrowski et al., 2019). Recently
such qualitative approaches have been criticised for being
narrow in scope or superﬁcial in eliciting contextual data
(Haines et al., 2021).
In our implementation science study, we propose the need
to adopt qualitative methods that could instead deliver speedy
actionable results in a complex precision medicine context yet
still maintain rigour (Nevedal et al., 2021; Smith et al., 2020b).
Therefore, we sought rapid methods that could contend with
the intervention context and chose to apply a novel, rapid
ethnographic methodology to generate ﬁndings in a timely
manner and ensure the study researcher moves with study
participants as they go about their work lives (Rapport et al.,
2020). In this way, rapid ethnography allows examination of
the people, the organisations, and the different system-level
under consideration and change over time in a contemporary
fashion (Rapport et al., 2020). However, speedy data collection is of limited use if the data analysis still proceeds at the
painstakingly slow rate that is typical of most qualitative
research (Millen et al., 2000). Sentiment Analysis is a candidate for resolving that deﬁcit in a rapid way. In line with this
paradigm shift, our implementation science study proposes the
need for rapid qualitative analysis of the deductive CFIR
approach (Gale et al., 2019; Nevedal et al., 2021; Zucco et al.,
2021) through the use of Sentiment Analysis. Sentiment
Analysis (Pang & Lee, 2008; Pinto et al., 2018) identiﬁes and
categorises opinions to determine whether participants’ attitudes toward a particular topic (intervention or product, etc.)
are positive or negative. Sentiment Analysis, therefore, has the
potential to help in the rapid analysis of the CFIR approach
and is in keeping with a new awareness of the value of turning
from implementation to rapid implementation in all respects
(Smith et al., 2020b). Sentiment Analysis offers the CFIR
approach a new way to rapidly detect the range of sentiments
displayed and sentiment polarity from large qualitative data
sets while providing timely results in rapidly changing environments (Coppersmith et al., 2015; Golder & Macy, 2011;
Gore et al., 2015; Zhou et al., 2015). Sentiment Analysis has
successfully been applied to several health interventions to
date, such as vaccination (Dunn et al., 2015; Naseem et al.,
2021; Zhou et al., 2015), mental health (Oyebode et al., 2020)
and the delivery of outcomes such as those relating to seasonal
affective disorder and obesity (Coppersmith et al., 2015;
Golder & Macy, 2011; Gore et al., 2015). The CFIR approach
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will be helped by Sentiment Analysis by maturing the
framework (Smith, 2022) because of its speedy processing of
large qualitative data sets (such as rapid ethnographic ﬁeldnotes) in a short amount of time (Fondevila-Gascón et al.,
2016; Morgan et al., 2021; Willson et al., 2021; Zhou et al.,
2015).
This paper presents a novel methodological roadmap on
how we can speed up qualitative data collection and analysis
to provide an understanding of qualitative data in a highly
complex, multi-faceted and ever-changing tailored intervention. It also examines barriers and enablers to implementation
and has an overarching goal of providing insights into key
barriers to implementation success (Damschroder et al.,
2009).

Study Aim
Study aims were derived from multi-stakeholder meetings and
discussions between ZERO Program partners, universitybased researchers, and implementation scientists in Australia.
This study aimed to:
(1) Provide a methodology to identify barriers and enablers to the delivery of a childhood cancer personalised medicine Program (the ZERO Program).
(2) Assess key enablers and barriers in real-time care
delivery according to stakeholders’ strength of feeling
and order of importance.

Method
Study Setting
Data were collected from the multicentre study’s eight sites
(eight hospitals in the ZERO Program and PRISM) through a
central site in Sydney, hosting CMs and MTBs in person and
available via video link for those not in the state. In addition, as
part of a rapid ethnography, purposeful informal conversations
took place at the central site to capture the views and experiences of key players regarding the complex intervention.

Study Population
The ZERO Program Operations and Program Managers
identiﬁed key players to take part in data collection who were
directly responsible for design, delivery and oversight. The
researchers regularly sought out the lead person making the
decisions about progress and implementation. Key players
comprised of various clinical and non-clinical staff members
representing different disciplines. Work across sites was
collaborative.
While data were collected from one central site, CMs and
MTBs brought JS, a male researcher who is experienced in
rapid ethnography, into contact with: clinicians, curation
specialists, administrators, managers, technicians and
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laboratory scientists, who were themselves in discussion with
treating paediatric oncologists of children with high risk
paediatric malignancies (expected survival <30%).

The Application of Rapid Ethnography
Data Collection. Ethical approval was granted by the Hunter
New England Research Ethics Committee, New South Wales,
Australia. Approval number: 2019/ETH12025. Purposive
sampling was used, with an opt-out consent process for the
rapid ethnographic research approved and followed. For
observations, this process is appropriate in identifying and
managing participants and non-participants as any number or
combination of healthcare professionals or other Program
members (participants) may also come into contact with the
study researcher during a given observation period. It is also
hard to anticipate participants in advance of the research
taking place. Program managers provided advance notice and
information about the study to various teams involved, anticipated to be involved or present at planned observations. JS
also wore a badge detailing his name and a “research in
progress” annotation so that incidentally observed participants
were made aware of the research taking place and could optout of study involvement (become a non-participant). The
study had no staff opt-outs. As opposed to some of the historical anthropology studies suggesting spending around
2 years in the ﬁeld, our implementation science study consisted of a 9-month intensive rapid ethnographic data collection period (Vindrola-Padros & Vindrola-Padros, 2017)
whilst simultaneously focusing on ongoing intervention optimisation (Chambers et al., 2013; Rapport et al., 2020). This
intensive timeframe enabled JS as the lone ﬁeld researcher to
immerse himself in the ZERO Program context, attend CMs
and MTBs, and undertake observations and informal conversations with individuals in the ZERO Program. Data were
collected from clinicians and other stakeholders in line with
study aims, examining: (a) how the ZERO Program functioned, (b) Program activities and meetings (to determine the
faithfulness to or departures from the intended intervention),
(c) collaborations and interactions (to clarify characteristics of
individuals and the inﬂuence of setting characteristics) and (d)
decision-making and information-sharing. While the focus
was on barriers and enablers of intervention design characteristics, it was also important to consider contextual factors to
delivery and implementation, allowing a nuanced picture to
emerge of individual and group activity, environments, events,
and personal circumstances. Fieldnotes were completed
during each event taking place for reliable record-keeping
(Smith et al., 2020a). Fieldnotes included commentary on the
dynamics of different meetings and non-verbal communication. As data were collected, they were de-identiﬁed, and
quotations were anonymised. All participants were given
pseudonyms ready for the application of a CFIR coding
framework according to a CFIR codebook. There was no
attempt to capture data saturation, in line with research in
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ethnography (Jones & Smith, 2017; Streubert & Carpenter, 1996)
and reﬂexive thematic analysis (Braun & Clarke, 2021). We
recognise that our ethnographic contribution is interpretative, and meaning is generated through the interpretation of
data.
Analysis. Framework Analysis (Ritchie & Spencer, 2002),
according to ﬁve distinct but related stages, was used to
structure and explore the data (Smith et al., 2020c), as outlined
in Table 1. JS led the analysis. Qualitative data was managed
through NVivo 12 Plus, a qualitative data analysis software
facilitating the collection, organising and analysis of data
(QSR, 2019). The initial framework was based on CFIR’s ﬁve
major coding domains: (1) Intervention design characteristics,
(2) Outer setting, (3) Inner setting, (4) Characteristics of individuals and (5) Process implementation, to which data was
deductively coded. In addition, domain deﬁnitions were tailored for relevance to the paediatric precision medicine intervention. Like past studies before us (Keith et al., 2017;
McDonald, 2013; Means et al., 2020; Safaeinili et al., 2020),
we reﬁned CFIR into its intervention design characteristics
and contextual characteristics to better ﬁt the precision
medicine context (Chambers et al., 2016; Damschroder et al.,
2022; Levy et al., 2019; Wong et al., 2020; Zebrowski et al.,
2019). Additional codes were incorporated into the codebook
(e.g., speed of delivery and design quality and safety) as they
emerged through close reading of the data, with tailored
deﬁnitions making CFIR relevant to the ZERO Program
following previous qualitative studies using CFIR within this
context (Zebrowski et al., 2019). Codes helped structure the
identiﬁcation of both intervention design characteristics and
contextual characteristics. Codes were further analysed using
Sentiment Analysis (positive, negative, moderately positive,
moderately negative). The “queries” function in NVivo
generated counts of code incidences across factors and sentiments, leading to a matrix quantifying qualitative data,
juxtaposing codes with sentiments, and grading content delivery (Smith et al., 2021b). The process was supported by
researchers discussing data as the framework took shape.
Implementation Scientists (JS, FR, JB, JL) helped clarify
barriers or bottlenecks to implementation. Groupwork led to a
ﬁnal CFIR framework indicating key aspects of Program
delivery. We represent our qualitative ﬁndings through a visual
presentation to appeal to and facilitate understanding amongst
clinicians and other stakeholders (Smith et al., 2020c, 2021b).

Results
Thirty-eight different data collection events took place (Table
2). JS spent 30 min to half a day at the data collection site on
each occasion, working across settings and attending meetings
as required. Observational episodes included informal conversations (30 min to 1 h) and MTB and CM meetings (1 h).
There were no important harms to note or unintended effects to
consider in each group in carrying out our study (Table 2).
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Table 1. Methodological roadmap.
Framework Analysis Stages

Description

1. Familiarisation
2. Identifying a thematic
framework
3. Indexing
4. Charting

Fieldnotes are read and re-read to absorption
Select text for coding /begin to develop categories based on CFIR codes (deductive)a

Comparing and contrasting data from ﬁeldnotes, observations, and informal conversations
Arrange CFIR codes (deductive)a and where necessary add to the codes to support full data understanding.
Employ sentiment analysisb to clarify the degree of positive or negative sentiment around each code, and
determine the strength of feeling over different data aspects
5. Mapping and interpretation Triangulate data across all datasets, reviewing connections or disconnections, removing overlapping codes,
describing, and interpreting data ﬁndings, and building consensus through groupwork activities around ﬁnal
framework factors (intervention design characteristics and contextual factors). Finally, the ﬁndings from
the qualitative data can be graded and quantitatively displayed
a

CFIR: Intervention characteristics, inner setting, outer setting, individual characteristics, process implementation.
Sentiment Analysis: moderately positive, very positive, moderately negative, very negative.

b

Table 2. Data capture events.
Type of data
capture event

Number of data
capture events

Range of staff attending
each event

MTB meetings

14

14–45

CM meetings

14

6–14

Individuals

10

1–2

Rapid ethnography

Role

Gender

Observation and
ﬁeldnotes
Observation and
ﬁeldnotes
Informal conversation and
ﬁeldnotes

Multi-disciplinary team
member
Multi-disciplinary team
member
a
Joanna
Laura
Lesley
Lucy
Jenny
Diego
Connor
John
b
Henrietta and Harriet
(attended together)

Mixed
group
Mixed
group

Female (7)
Male (3)

a

All individuals have een given pseudonyms to protect their identity.
Henrietta and Harriet met JS together.

b

Grading and Visual Presentation of Data
Intervention design characteristics and contextual characteristics, and within intervention design characteristics, a
concentration on those indicating adaptability, design quality
and safety, cost, evidence strength and quality, speed of
delivery, complexity, and trialability, while contextual
characteristics covered: Inner setting, Outer context, Individual characteristics and Process (Table 3). Table 3 also
highlights where data came from (CMs, MTBs, informal
conversations), the type of sentiment expressed (positive or
negative) and the strength of sentiment (moderately positive,
positive, moderately negative, negative). This provides a
clearer understanding of the impact (barrier or enabler) likely
to affect implementation success as well as what was seen to
be working well.

There was a higher percentage of total negative sentiments
for all factors (N) according to each data capture event (n) for
both intervention design characteristics (negative sentiment: N
= 165, n = 114, 69.1%) and contextual characteristics (negative
sentiment: N = 71, n = 38, 53.5%) compared to positive
sentiment for intervention design characteristics (N = 165, n =
51, 30.9%) and contextual characteristics (N = 71, n = 33,
46.5%). This indicates perceptions of more barriers than enablers, particularly regarding key implementation features
available in Table 3. For individual intervention design characteristics factors, “Adaptability” was the strongest enabler (N =
21, n = 14, 66.7%) and “Design quality and safety” the strongest
barrier (N = 14, n = 13, 92.9%) while for contextual characteristics, “Networks and communication” (N = 8, n = 8,
100.0%) was the strongest enabler, and “Available resources”
the strongest barrier (N = 4, n = 4, 100.0%) (Table 3).

1
2
2
5
25
29
5
59

Cost: Various aspects of the intervention
associated with cost

Inner setting
Networks and communication: Reliance on a broad
and diverse internal network of health
professionals

Contextual characteristics

Complexity: Interpretation of complex genomic
data and as a result, the perceived difﬁculty of
implementing the intervention for each
individual case
Trialability: Pilot trial, TARGET, had laid
groundwork for PRISM

Speed of delivery: The speed of delivery of the
intervention associated with critical
turnaround time from CM’s to MTB’s

3
1
4
8

N

5
9
N/A
14

Design quality and safety: Tumour samples
collected and quality-control as per
the intervention

2
6
6
14
16
33
1
50
NA
NA
2
2

9
12
NA
21

Adaptability: The degree to which
the intervention could be adapted

Evidence, strength and quality: Rapidly changing
genomic evidence base and the inﬂuence this
has on the intervention

N

Overall

71

Intervention design characteristics

Overall

165

Overall
Intervention design characteristics
Overall
Contextual charateristics

Data capture

N

Domain

MTB
CM
Individual
Total

Data capture

MTB
CM
Individual
Total
MTB
CM
Individual
Total
MTB
CM
Individual
Total

MTB
CM
Individual
Total
MTB
CM
Individual
Total

MTB
CM
Individual
Total

MTB
CM
Individual
Total

Data capture

0
0
0
0

2
2
2
6 (42.9%)
4
20
0
24 (48.0%)
NA
NA
1
1 (50.0%)

1
1
2
4 (80.0%)
13
16
2
31 (52.5%)

5
8
NA
13 (92.9%)

0
4
NA
4 (19.0%)

0
0
0
0

Very negative
n (%)

Negative sentiment

Moderately negative n (%)

0
1
3
4 (28.6%)
5
5
1
11 (22.0%)
NA
NA
0
0

0
0
0
0
5
7
1
13 (22.0%)

0
0
NA
0

1
2
NA
3 (14.3%)

Very negative n (%)

0
0
0
0

Total negative
views n (%)

2
3
5
10 (71.4%)
9
25
1
35 (70.0%)
NA
NA
1
1 (50.0%)

1
1
2
4 (80.0%)
18
23
3
44 (74.6%)

5
8
N/A
13 (92.9%)

1
6
NA
7 (33.3%)

0
0
0
0

3
1
4
8 (100%)

Very positive
n (%)

Positive sentiment

0
1
1
2 (14.3%)
1
0
0
1 (2.0%)
NA
NA
1
1 (50.0%

0
1
0
1 (20.0%)
5
2
2
9 (15.3%)

0
0
NA
0

4
2
NA
6 (28.6%)

Very positive
n (%)

Positive sentiment

25 (35.2%)

20 (12.1%)

Very positive n (%)

Positive Sentiment

Moderately positive
n (%)

0
2
0
2 (14.3%)
6
8
0
14 (28.0%)
NA
NA
0
0

0
0
0
0
2
4
0
6 (10.2%)

0
1
NA
1 (7.1%)

4
4
NA
8 (38.1%)

Moderately
positive n (%)

8 (11.3%)

31 (18.8%)

Moderately
positive n (%)

Total Negative
views n (%)

38 (53.5%)

114 (69.1%)

Total
Negative views n (%)

Negative sentiment

28 (39.4%)

83 (50.3%)

Very negative n (%)

Moderately negative n (%)

10 (14.1%)

31 (18.8%)

Moderately negative n (%)

Negative Sentiment

Table 3. Grading data: A visual presentation of the intervention design and contextual characteristics across data collection events.

3
1
4
8 (100%)

Total positive
views n (%)

0
3
1
4 (28.6%)
7
8
0
15 (30.0%)
NA
NA
1
1 (50.0%)

0
1
0
1 (20.0%)
7
6
2
15 (25.4%)

0
1
NA
1 (7.1%)

8
6
NA
14 (66.7%)

Total positive
views n (%)

33 (46.5%)

51 (30.9%)

Total positive
views n (%)

(continued)

Enabler
Enabler
Enabler
Enabler
Enabler

Barrier/Enabler

Enabler
Barrier & enabler
NA
Enabler
Barrier
Barrier
NA
Barrier
Barrier
Barrier & enabler
Barrier
Barrier
Barrier
Barrier
Barrier
Barrier
Barrier
Barrier & enabler
Barrier
Barrier
Barrier
Barrier
Barrier
Barrier
NA
NA
Barrier & enabler
Barrier & enabler

Barrier/
enabler

Barrier

Barrier

Barrier/enabler
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*MTB
*CM
Individual
Total
Overall total

16

Overall total

6
NA
NA
16
16

MTB
CM
*Individual
Total

Overall total

25
5
1
NA
6

MTB
CM
Individual
Total
MTB
CM
Individual
Total

Overall total

24
6
4
1
11
9
4
1
14

MTB
CM
*Individual
Total
MTB
CM
Individual
Total

Data capture

2
10
NA
12
NA
NA
4
4

N

3 (18.8%)

NA
NA
3
3 (18.8%)

1 (16.7%)

1
0
NA
1 (16.7%)

5 (20.0%)

2
1
0
3 (27.3%)
2
0
0
2 (14.3)

1 (4.2%)

0
1
NA
1 (8.3%)
NA
NA
0
0

Moderately negative n (%)

7 (43.8%)

NA
NA
7
7 (43.8%)

4 (66.7%)

3
1
NA
4 (66.7%)

13 (52.0%)

4
3
0
7 (63.6%)
3
3
0
6 (42.9%)

4 (16.7%)

0
0
NA
0
NA
NA
4
4 (100%)

Very negative
n (%)

Negative sentiment

10 (62.5%)

NA
NA
10
10 (62.5%)

5 (83.3%)

4
1
NA
5 (83.3%)

18 (72.0%)

6
4
0
10 (90.9%)
5
3
0
8 (57.1%)

5 (20.8%)

0
1
NA
1 (8.3%)
NA
NA
4
4 (100%

Total negative
views n (%)

0

NA
NA
0
0

0

0
0
NA
0

5 (20.0%)

0
0
1
1 (9.1%)
3
1
0
4 (28.6%)

3 (12.5%)

1
2
NA
3 (25.0%)
NA
NA
0
0

Moderately positive
n (%)

6 (37.5%)

NA
NA
6
6 (37.5%)

1 (16.7%)

1
0
NA
1 (16.7%)

2 (8.0%)

0
0
0
0
1
0
1
2 (14.3%)

16 (66.7%)

1
7
NA
8 (66.7%)
NA
NA
0
0

Very positive
n (%)

Positive sentiment

6 (37.5%)

NA
NA
6
6 (37.5%)

1 (16.7%)

1
0
NA
1 (16.7%)

7 (28.0%)

0
0
1
1 (9.1%)
4
1
1
6 (42.9%)

19 (79.2%)

2
9
NA
11 (91.7%)
NA
NA
0
0

Total positive
views n (%)

Enabler
Barrier
Barrier
Barrier
Enabler
Barrier
Barrier
Barrier
Enabler
Barrier
Barrier
Barrier
Barrier
Barrier
NA
Barrier
Barrier
Barrier
NA
NA
Barrier
Barrier
Barrier

Enabler
Enabler
NA
Enabler
NA
NA
Barrier
Barrier

Barrier/Enabler

KEY: Trafﬁc light system: Barriers are represented in red = The total negative percentage is higher than the total positive percentage; Enablers are shown in green = The total positive percentage is higher than the
total negative percentage; Barrier & Enabler are represented in Orange: The total number of barriers and enablers are equal.
N= Total number of references coded across sentiment; n= Number of references coded across sentiment for each data collection activity; 0= Participant had the opportunity to discuss this, but did not discuss
it; NA= not applicable as this component was not present during data capture.

Individual characteristics
Knowledge and beliefs: Attitudes held toward
knowledge in the wider medical profession

Implementation process
Planning: Running of MTB and CM meetings

Cosmopolitanism: Mix of externally connected
networks requiring full collaboration

Outer setting
External policy and incentives: External policy
and regulatory environment

Available resources: Infrastructure and resources
inﬂuencing delivery

Rapid learning system: Availability of sudden
learning opportunities

Contextual characteristics

Table 3. (continued)
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Intervention Design Characteristics: Key Themes
Adaptability: An Enabler Overall for Intervention Application and
Applicability. “Adaptability” is the degree to which the intervention ﬁts the needs of the people, sites and settings and
appears to be a strong enabler to overall intervention applicability. To be adaptable relies on the intervention’s ability to
accommodate people’s behaviours and relationships, but also
healthcare structures and systems through which the intervention is being introduced. For example, positive sentiment
from MTBs towards the adaptation of treatment protocols and
changes to clinical practice that might enable children, who
were not originally eligible to be part of the precision medicine
program, to now be eligible. Within the CMs, adaptability as
an enabler for intervention application, related to the adaptation of databases and technologies within healthcare systems, the addition of new technologies (for example, a “tape
station” that would enable methylation to be an internal as
opposed to an outsourced process), and the updating of existing technology. No data were gleaned for ‘adaptability’
from informal conversations.
Design Quality and Safety: A Barrier to Implementation. “Design
quality and safety” relates to how the intervention is perceived
to ensure such aspects as quality and safety as an absolute
priority within the intervention. However, this was a component that was perceived to be a barrier to implementation.
This was due to the identiﬁcation of a small number of instances where the arrival of poor samples or quality-control
issues relating to tumour samples were perceived as aspects
not yet solved. For example, CMs focused on bad samples,
small tumour samples, degraded material, and the lack of
quality control in terms of potential processing errors and
batch effects. MTBs focused on the quality and size of the
tumour (coming from bone or containing lots of contaminated
cells). No data were forthcoming on this aspect from individual informal conversations.
Cost: An Overall Barrier to Implementation. “Cost” relates to
how much the intervention costs in terms of testing and data
retrieval, which was seen as an overall barrier to implementation, with MTBs and CMs concentrating on costs to
carry out extra tests. Yet, for CM attendees, there were some
positive views expressed about ﬁnding new ways to reduce
costs, such as upfront testing or conducting a pilot. During
informal conversations, concerns were also voiced about
costs, expressly the cost of storing and retrieving data from
high-performance data storage systems.
Evidence,
Strength
and
Quality:
A
Barrier
to
Implementation. “Evidence, strength and quality” relates to
the strength of the evidence supported by either good strong
high-quality evidence or weak evidence. When evidence,
strength and quality from evidential sources was lacking (e.g.,
the strength of evidence in relation to a lack of current
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published literature), this was perceived as a barrier to informing diagnostic and treatment decisions, as key players
questioned whether sources of information were reliable and
continued to question whether more evidence was available.
During MTBs, negative sentiments were expressed regarding
a lack of information sources for paediatric treatment dosages,
drug combinations, and tumour use during drug screening, as
well as concerns about evidence-use in these areas. Within
CMs, similar issues were raised regarding poor-quality information or lack of information sources on these topics. In
CMs, positive sentiments were also voiced around cases that
presented good-quality data shared on a server. One informal
conversation with Lesley focused on concerns over poorquality evidence regarding toxicity and dosage and the
need for recommendations for new toxicity and dosage
practices to build a stronger evidence-base.
Speed of Delivery: A Barrier to Implementation. “Speed of delivery” of the intervention was perceived as both a barrier and
an enabler to implementation, while the overall strength of
feeling placed this as a barrier to implementation (delays in
delivery). MTB’s focused on problems with delays for
methylation, while CMs questioned why methylation lagged
behind the presentation of cases at MTB, such that results were
not timely and had to be reviewed a second time, by which
time people had forgotten about the case. This led to questions
about how to present information more effectively. CMs indicated an equal mix of negative and positive sentiment regarding optimising curation workﬂow. In informal
conversations, speed was perceived as an enabler to optimising turnaround through automation processes but equally a
barrier; reducing time meant having less time to discuss the
complexity of cases.
Complexity: A Barrier to Intervention Implementation. “Complexity”
relates to the perceived difﬁculty of implementing the intervention, the more complex an intervention, the more
difﬁcult it will be to implement. In MTBs difﬁculties concerned: (1) what to report in complex cases; (2) what recommendations to make; and (3) what the treating oncologist
should be communicating to patients in a complex case. In
CMs, negative sentiments focused on the complexity of
managing issues raised in MTBs, speciﬁcally around the
complex nature of precision medicine and the interpretation
of novel data. From informal conversations, perceived difﬁculties surrounded the complexity of individualising
treatments and managing patients with complex disease
presentations, especially children who had exhausted all
other avenues of treatment; as Joanna stated, complex cases
where children’s only hope for survival is enrolment on the
ZERO Program or PRISM trial.
Trialability: A Barrier and an Enabler to Implementation. “Trialability,”
the testing of the intervention on a small scale, helps to
show the intervention can be achieved before it is
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implemented on a much larger scale. Trialability was both
perceived as a barrier and an enabler to implementation.
Trialability (represented by a pre-ZERO efﬁcacy study:
TARGET) was not discussed during either MTBs or CMs,
but in informal conversations, it was raised on occasion. Some
study participants, like Henrietta and Harriet, compared the trialability of TARGET to the provision of comparative data for the
full PRISM national trial and that the efﬁcacy pilot study aimed at
achieving feasibility had received better quality tumours compared
to the national PRISM trial. In this respect, Henrietta and Harriet
felt that TARGET received better support in the form of an engaged and willing staff. It is important to note, that TARGET was a
much smaller feasibility study and easier to manage when
compared to the national PRISM study. No data were returned to families or clinicians regarding whether tests for
precision medicine could be achieved. John echoed this
position and further explained that PRISM morphed into
something better than TARGET. It was generating evidence
locally that would have relevance for the whole country,
aligning to international standards.

Contextual Characteristics: Key Themes
Inner Setting
Networks and Communication: Enablers for Implementation. “Internal
networks” were perceived as clear enablers and related to
how individuals communicated with other members of
their internal groups, with the success of this depending on
the people in small collaborative teams, who then made-up
Program networks. It was teamwork and how “networked”
team members were at a local level that was the deciding
factor for people to positively inﬂuence implementation.
MTBs were seen as the place where staff could focus on
cases and highlighted interdependencies between members
of internal networks and specialists with unique skills on
speciﬁc trials. CMs focused on the network of individuals
(inner network) that empowered people to raise clinical
questions. During informal conversations, individuals such
as Henrietta and Harriet, Joanna and Diego spoke of key
people in their inner network and staff members they relied
upon. Overall, networks were seen to foster good communication and ongoing collaboration between staff
members, helping people focus on clinically relevant
questions.
Rapid Learning Systems: An Enabler to Implementation. “Rapid
Learning Systems” (Riley et al., 2013) focus on learning and
evidence development and were enablers to implementation,
encouraging healthcare workers to be in an appropriate position to take advantage of sudden learning opportunities.
MTBs and CMs included expert advisory clinicians (or
mentors) who were seen as crucial for underpinning the
positive effect of Rapid Learning Systems, alongside curation
and bioinformatic specialists working in paediatric precision

9

medicine. Evidence from MTBs indicated that Rapid Learning
Systems helped junior staff and supported other clinicians and
treating oncologists to discuss patients, while attendance at
both MTBs and CMs offered opportunities for new Rapid
Learning Systems to come to fruition in terms of ongoing
learning and evidence development. Within CMs, senior
clinicians’ and curation specialists’ knowledge helped conceptualise Rapid Learning activities, particularly in line with
complex novel cases. There was no coded data on this subject
from informal conversations.
Available Resources: A Barrier for Individuals. “Available resources,” in the form of infrastructure and time, were said to
be barriers to implementation, while resources were said to
have been diverted to the overall Program and ongoing operations. Overall, negative sentiment was expressed by individuals during informal conversations, with mention of
annoying bottlenecks and challenges to resource delivery.
Jenny, for example, remarked that there were problems with
data storage and inadequate infrastructure to handle the speed
and amount of data that came into the ZERO Program.
Henrietta, Harriet and Jenny mentioned inefﬁciencies within
resource use, and Henrietta and Harriet drew attention to
problems with small amounts of tumours available for research purposes that impacted precision medicine recommendations and reports (reports include interpretation of test
results, and potentially actionable recommendations, for example, novel drug targets and change in diagnosis) delivered
to the treating physician.

Outer Setting
External Policies and Incentives: A Barrier to Implementation. “External
policies and incentives” focus on regulations (governmentled) and guidelines (surrounding cutting-edge work of the
ZERO Program) with particular emphasis on the work of
PRISM. Within CMs, the focus was on the restrictions
resulting from regulation and the impact on access to trial
data, Food and Drug Administration approval (FDA Food and Drug Administration), and the ability to bypass
“X” organisation to talk directly to “Y.” At MTBs, strongly
voiced negative sentiment was expressed regarding drug
access and trial data. External policies were also considered barriers to trial access and Therapeutic Goods
Administration approval (TGA – Australia’s Food and
Drug Administration). Nevertheless, during informal
conversations, external policies shone as enablers, as John
suggested bolting on external trials to the Program work
to do a proper evaluation of trial effectiveness and access.
John also mentioned that while compassionate drug access
was effective, there was no way to evaluate it (uncontrolled anecdotal outcome and not useable from a clinical
perspective), and thus evidence around the value of
compassionate access became more anecdotal than
concrete.
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Cosmopolitanism: A Barrier to Implementation. “Cosmopolitanism”
is the degree to which the organisation underpinning the
work of the ZERO Program and PRISM was externally
connected and networked with other organisations. Cosmopolitanism was perceived as a barrier in CMs and
marginally a barrier in MTBs. MTBs focused more on the
positive sentiment of the sponsor, the trial, and the external
networks (such as visiting professors and genetic counsellors). CMs expressed more negative sentiments towards
connectivity with other organisations, raising issues regarding getting feedback from others on the uncertainty of a
test result and the problems stemming from a lack of ﬁrm
relationships with drug companies, while positive sentiments focused on being able to seek national expert advice
on novel test results. During an informal conversation about
what was being delivered in the ZERO Program and
PRISM, cosmopolitanism was seen as an enabler. Joanna
commented that the ZERO Program delivered much more
than other countries had been able to achieve as well as
being able to deal with more complex cancer cases than in
other countries, for example.

Implementation Process
Planning: A Barrier to Implementation
“Planning,” the actual process of preparing for implementation was clearly hindered (poor communication
within planning) by work being undertaken during dial-in
meetings at MTBs and CMs, as this impacted upon implementation process. As a result, planning was listed as a
barrier to implementation. During MTBs and CMs, attendees noted that important details were often hard to hear.
In addition, a number of conversations were interrupted by
unplanned situations or issues with video cameras or personal dial-ins. This led to some meetings being abruptly
abandoned before arrangements were ﬁnalised, as such
cases were rearranged where they were to be presented at a
later date.

Individual Characteristics
Knowledge and Beliefs: A Barrier to Implementation. “Knowledge
and beliefs” relate to attitudes and beliefs held about current
knowledge that represented a barrier to implementation.
Lesley spoke informally to JS about her lack of knowledge
in terms of a sense that technology provides a way to
capture a lot of genomic data, yet there was much still
unknown within the ﬁeld of genomics on how to interpret
some of this data, which resulted in holding ﬁrm to longheld beliefs about the right approach to take. This is known
as “clinical equipoise,” being guided by one’s own
standpoint. For example, key players mentioned that there
was a general lack of knowledge in the wider medical
profession (particularly amongst clinicians) about precision
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medicine and some aspects of Program development and
delivery, which in turn inﬂuenced attitudes towards the
intervention and led to a lack of familiarity with the full
facts. Informal conversations with John and Connor, indicated that educational forums (including Continued
Professional Development) were not being attended because of a general lack of interest in upskilling, leading to a
lack of important complex, highly specialised understanding and ability. John remarked that there were educational barriers, such as in paediatric oncology, with
people often uneducated about precision medicine. Henrietta and Harriet also discussed a lack of knowledge
amongst colleagues and remarked that there was a clear
need for more information upfront and educational events,
which would lead to greater understanding and clearer
collaboration, particularly for paediatric oncologists.

Summary of ﬁndings
In summary, the descriptions above highlight that the enablers
listed were (in order of importance): (1) “Networks and
communication” (N = 8, n = 8, 100%), (2) “Rapid Learning
Systems” (N = 12, n = 11, 91.7%) and (3) “Adaptability” (N =
21, n = 14, 66.7%).
Intervention design characteristics that were barriers (in
order of importance) were: (1) “Design quality and safety”
(N = 14, n = 13, 92.9%), (2) “Cost” (N = 5, n = 4, 80.0%), (3)
“Evidence, strength and quality” (N = 59, n = 44, 74.6%), (4)
“Speed of delivery” (overall a barrier though included an
enabler component) (N = 14, n = 10, 71.4%), (5) “Complexity” (N = 50, n = 35, 70.0%) and (6) “Trialability” (overall
a barrier though it included an enabler component) (N = 2, n =
1, 50.0%).
Contextual factors that were barriers (in order of importance) were: (1) “Available resources” (N = 4, n = 4, 100%),
(2) “External policy and incentives” (N = 11, n = 10, 90.9%),
(3) “Planning” (N = 6, n = 5, 83.3%), (4) “Knowledge and
beliefs” (N = 16, n = 10, 62.5%), and (5) “Cosmopolitanism”
(N = 14, n = 8, 57.1%).
Reviewing intervention design characteristics and
contextual factors to determine the order in which dominant barriers need addressing, the three most pressing
issues were: (1) “Available resources” (N = 4, n = 4,
100%), (2) “Design quality and safety” (N = 14, n = 13,
92.9%), (3) “External policy and incentives” (N = 11, n =
10, 90.9%).
Overall, the individual intervention design characteristics
and contextual characteristics, when considered in their
constituent domains, in order of importance of domains
(according to barriers) were: (1) “Implementation process” (N
= 6, n = 5, 83.3%), (2) “Outer setting” (N = 25, n = 18, 72.0%),
(3) “Intervention characteristics” (N = 165, n = 114, 69.1%),
and (4) “Individual characteristics” (N = 16, n = 10, 62.5%)
(Table 3).
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Discussion
This study provides a methodological roadmap to help rapidly
identify determinants of change. To our knowledge, this is the
ﬁrst study to: (1) specify aspects of determinants of change in
paediatric precision medicine to operationalise a method to
assess intervention design characteristics and contextual
characteristics in real-time, (2) convert rapid ethnographic
datasets according to strength of feeling against each factor,
and (3) comprehensively “opinion-mine” to understand barriers and enablers to implementation in order of need. Thus,
we locate this research in terms of both “the art and science of
implementation” within the context of a complex tailored
intervention in childhood cancer.
Implementation science can rapidly speed up the translation of basic and clinical genomic research ﬁndings by
evaluating how individuals, groups and systems behave and
then applying that knowledge to determine how well an intervention is being implemented by those involved across
different system-levels in different contexts. For example, as
new drugs are developed and as new gene targets are identiﬁed
in precision medicine (Horton & Lucassen, 2019), this brings
into question, how does implementing evidence-based practice ﬁt within the ethos of implementation science, if that very
evidence is still evolving (Chambers et al., 2016; Manolio
et al., 2013; National Academies of Sciences & Medicine,
2016)? There is a new opportunity to learn from both genomics research and newly developed evidence on COVID-19
(Chambers, 2020; Randhawa et al., 2020; Wilder-Smith et al.,
2020) since these two settings show evidence-based practice
can and is implemented at the same time as we are still
learning and at the same time as new evidence is still being
generated (Curran et al., 2012; Lane-Fall et al., 2019; Smith
et al., 2020b). For example, the rapid pace at which precision
medicine changes and the subsequent demands this places on
healthcare professionals is challenging researchers to use more
innovative methodologies to deliver actionable results in a
more rapid way (Smith et al., 2020b).
We applied a rapid ethnographic methodology with observation methods such as physically travelling alongside
participants by attending multidisciplinary meeting arrangements and having informal conversations to generate rich
contextual information on barriers and enablers of a precision
medicine intervention. This was in line with recent criticism
directed at more standard methods (interviews as the preeminent method of choice) in terms of their superﬁcial elicitation of contextual data from interviews combined with their
time and resource-intensive approach (Haines et al., 2021).
Such slow and static methods like interviews appear counterintuitive to the speed with which precision medicine
changes within the childhood cancer context. Therefore, our
method has a comparative advantage over other qualitative
methods currently used that fail to recognise the importance of
context and not generating ﬁndings quickly and effectively. In
addition, researchers should move towards determinant
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frameworks (barriers and/enablers) in precision medicine
(Bangash & Kullo, 2020; Roberts et al., 2017) and speed up
qualitative research quickly and effectively (Gale et al., 2019;
Smith et al., 2020b, 2021b) to meet demands within high stake
contexts (Smith et al., 2020b). To our knowledge, our study is
the ﬁrst of its kind to use a determinant framework (CFIR)
(Damschroder et al., 2009) together with Sentiment Analysis
(Pang & Lee, 2008; Pinto et al., 2018) to speedily determine
barriers and enablers of a precision medicine intervention. We
see an opportunity to apply our rapid data collection and
analytic roadmap to other precision medicine settings (e.g.,
adults with rare cancers or all children with cancer or genetic
referral and testing practices) to rapidly identify barriers
within these settings. Our methodology, therefore, has application beyond high risk childhood cancers, and can be used
in other precision medicine contexts as a way to avoid the
widely held practice of scaling a precision medicine intervention across entire states and populations without prior
identiﬁcation of the types of internal barriers or wider system
bottlenecks that could hinder successful implementation
(Bangash & Kullo, 2020; Roberts et al., 2017). The descriptor
“dynamic” that we use throughout our study refers to the rapid
evolution of the technology used in precision medicine, the
constant reﬁnement of processes, and the constantly changing
knowledge base as new genes are studied and reported. Our
methodological roadmap may therefore have intuitive appeal
within (Lewis et al., 2022) and across broader dynamic and
rapidly evolving environments such as its application within
the COVID-19 vaccination program as a diagnostic tool. Our
methodological roadmap would work well in assessing the
national vaccination program amid the emergence of rapid
viral variants causing ongoing changes to the evidence base as
new strains of COVID-19 evolve, such as the global spread of
the Omicron subvariant BA.1 and stealth Omicron BA.2 or
Fluorna (Chadeau-Hyam et al., 2022; Dejnirattisai et al., 2022;
Grabowski et al., 2022; He et al., 2021; Lyngse et al., 2022).
Our methodological roadmap has proved useful to implementation science to bridge this temporal evidence-topractice gap and bring context to the forefront of implementation science. It provides iterative improvements in
efﬁciencies while at the same time speedily identifying and
rapidly monitoring barriers of greatest concern. This could
lead to not only a reﬁnement of evidence-based practice but
enable ongoing implementation at the same time that new
genomic evidence is rapidly being generated. Similarly, whilst
more negative than positive sentiments were expressed overall
in our study across intervention design characteristics and
contextual characteristics, this is perhaps not unexpected when
speciﬁc to this context, there is a need for ongoing evidence
development at the same time as implementation (Chambers
et al., 2016). This is especially the case for intervention design
characteristics that pertain to “evidence strength and quality”
with a clear lack of published data in this context (in particular
regarding drug access and drug combinations in paediatric
precision medicine). It should also be reiterated that this is a
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novel Program, being tested in a clinical trial, involving
transdisciplinary groups, coming together in new conﬁgurations, which are expected to change both practice and care
management plans within what could be seen to be an
adequately-functioning system (Rushforth & Greenhalgh,
2020). As Sirkin et al. (2005) discovered (in business),
there are always conﬂicting opinions over the changes most
needed and the essential milestones necessary for measuring
success. Our ﬁndings should be considered in light of this fact,
while our study was delivered in the context of an early-phase
clinical trial, with clear boundaries and time dependencies.
However, enablers were in evidence, most noticeably in relation to: “Networks and communication” (a contextual factor), “Rapid Learning Systems” (a contextual factor) and
“Adaptability” (an intervention design characteristic’).
To explore this further, it is possible to link contextual
factors such as “Networks and Communication” and “Rapid
Learning Systems” with the intervention design characteristic;
“Adaptability” (Damschroder et al., 2009). Echoing the literature on the importance of interconnections (Damschroder
et al., 2022; Safaeinili et al., 2020) together these three enablers indicate how people share educational events or experience supportive learning environments and how
inﬂuential this can be in helping them to adapt to change to
successfully implement the intervention; engendering new
behaviours and new organisational work patterns. The ZERO
Program includes groups of key players working together
through larger networks across sites, sharing evidence and
knowledge in both CM’s and MTB’s.
Context does indeed matter (Damschroder et al., 2009;
Greenhalgh et al., 2004; Hawe et al., 2004; Kemp, 2016;
McDonald, 2013; Safaeinili et al., 2020; Wong et al., 2020).
Contextual factors clearly operate at multiple levels to impact
on implementation strategy and effectiveness. Providing a
methodology to identify and assess this brings us one step
closer to uncovering the intervention “black box.” Our
ﬁndings show that the inner layer is an important enabler, as
other studies have identiﬁed, which report on the success of
tailoring CFIR’s inner layers to reﬂect complexity within a
healthcare system (Safaeinili et al., 2020).
Our implementation science study focused on the ongoing
optimisation of an early-phase precision medicine intervention
by rapidly collecting and analysing information amid ongoing
change over time. We propose that our method can be used to
optimise and improve the types of design and delivery of
interventions through rapidly identifying barriers that can be
proactively addressed/brought into focus as they arise, rather
than not being ﬂagged until full-scale evaluation occurs.
Opportunistic iterative change in response to rapid feedback
supports intervention optimisation of the intervention in real
time. The opportunity, therefore, lies in understanding the
sentiment of those at the coalface. A central part of our method
is the ongoing improvement to ﬂatten out barriers before
scaling a pilot program by orders of magnitude because, by the
time the intervention is ﬁxed in effectiveness research, it is too

International Journal of Qualitative Methods

late to change or optimise. In taking this research forward, the
method could be integrated to examine the ﬁdelity (as clearly
deﬁned, a faithful implementation) and contextual aspects (as
implementation tailored to the circumstances, situation and
needs of the intervention recipients). Understanding this is
vital to tailoring implementation strategies and creating
greater surety over their long-term effectiveness and scale-up.
Using rapid ethnography, a rich, in-depth and “naturalistic”
dataset can be assembled from which to identify vital CFIR
factors. Furthermore, there is an opportunity to study how data
from both rapid ethnography and clinical trials improve both
implementation and treatment outcomes in real-world practice
settings (Chambers et al., 2016). Initial evidence for a newly
developed roadmap to speeding up qualitative data collection
and analysis in precision medicine has now been established.
Our intention in the future is for our methodology to be
embedded within rapid-cycle feedback loops (Braithwaite
et al., 2014; Rapport et al., 2020), where actionable ﬁndings are shared with stakeholders during implementation in
order to share interim discoveries and allow for Program
corrections over time. Our goal in the future is ongoing optimisation and co-design of tailored implementation strategies.
To achieve this, we need to be able to use our visual presentation of qualitative ﬁndings as a visual tool to appeal to
clinicians and other stakeholders and create a culture of
learning in ways that other qualitative approaches may not be
able to. With our newly established methodological roadmap,
the future is bright to be able to speedily identify speciﬁc
barriers that appear at different time points and address them in
real-time, and through our visual presentation of the qualitative data we now have a way of sense-making around immediate Program adaptions.

Limitations
We made the best use of purposeful data, our number of
observations is sufﬁce from informal conversations with
transdisciplinary healthcare professionals. Still, we recognise
that this type of real-world data is dependent on those people
most willing to speak to researchers during a busy workday
and may not have included all the key program inﬂuencers.
This study has depended on relatively small samples; expanding the population demographic would offer opportunities for a wider translation of ﬁndings. Finally, our study
must be recognised as a snapshot in time where attitudes may
change over the longitudinal course of a clinical trial.

Conclusion
This study provides a methodological roadmap for speedily
evaluating complex interventions in precision medicine and
advances implementation theory and research by providing a
novel approach to conduct a barriers and enablers analysis. It
is timely, as there are no guidelines on how to establish the
most effective way of doing this speedily in complex tailored
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interventions. We have attempted to provide a way to qualify
and grade the level of positivity or negativity towards implementation, using intervention design characteristics and
contextual assessment. This will not only support a growing
awareness of the value of context but also the successful
prediction of intervention outcomes whilst highlighting the
value of ﬂexibility in tailoring interventions, as situations and
circumstances can and do change. Careful ongoing evaluation
(Braithwaite et al., 2014) and intervention optimisation
(Chambers et al., 2013) and rapid qualitative assessment can
mitigate against the negative consequences of barriers to
implementation and ensure clearer predictions of implementation effectiveness.
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